4.7 Article

Persistent viral shedding of human adenovirus type 7 in children with severe pneumonia

Journal

JOURNAL OF MEDICAL VIROLOGY
Volume 93, Issue 8, Pages 4846-4855

Publisher

WILEY
DOI: 10.1002/jmv.26864

Keywords

adenovirus; persistent infection; respiratory tract; shedding

Categories

Funding

  1. Hunan Provincial Medicine and Health Research Program [B201611]
  2. China Mega-Project for Infectious Disease [2014ZX10004002]

Ask authors/readers for more resources

For children with severe HAdV pneumonia, the duration of viral shedding is longer, with slower decrease in viral load and longer persistence for HAdV-7 infection.
To understand host-pathogen interactions and develop effective prevention and control strategies for human adenovirus (HAdV), it is essential to explore the characteristics of HAdV shedding. Hospitalized children <14 years who had severe HAdV pneumonia were tested for HAdV DNA by quantitative real-time PCR in nasopharyngeal aspirate (NPA). A total of 132 children were enrolled, including 102 patients with HAdV type 7 (HAdV-7) infection and 12 patients with HAdV type 3 (HAdV-3) infection. A total of 1372 qualified NPA samples were collected. There was a significant negative correlation between the viral load of HAdV and the course of the disease (Spearman r = -0.547, p = .000). HAdV-7 load decreased at a rate of 0.089 log10 copies/mL per day (95% CI: -0.096 to -0.081; R-2 = 0.332), and the duration of viral shedding was predicted to be 96.9 days (y = 8.624-0.089x). However, HAdV-3 load decreased more quickly (95% CI: - 0.229 to - 0.143; R-2 = 0.403), and the duration of viral shedding was 51.4 days (y = 9.558-0.186x). The median viral load of the HAdV-7 group at weeks 2 and 3, and more than 3 weeks postinfection was higher than that of the HAdV-3 group. No significant differences in the duration of viral shedding were found in different gender, age (>2 vs. <= 2 years), and with or without underlying diseases groups. Viral shedding in children with severe HAdV pneumonia persisted, among which HAdV-7 lasted longer than 3 months and the viral load decreased slowly than HAdV-3.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Effects of interleukin-6 and IL-6/AMPK signaling pathway on mitochondrial biogenesis and astrocytes viability under experimental septic condition

Xiao-Lan Chen, Yang Wang, Wan-Wan Peng, Yi-Jun Zheng, Tian-Nan Zhang, Ping-Jun Wang, Jin-Da Huang, Qi-Yi Zeng

INTERNATIONAL IMMUNOPHARMACOLOGY (2018)

Article Cell Biology

Upregulation of UCP2 Expression Protects against LPS-Induced Oxidative Stress and Apoptosis in Cardiomyocytes

Jinda Huang, Wanwan Peng, Yijun Zheng, Hu Hao, Sitao Li, Yu Yao, Yue Ding, Junliang Zhang, Juanjuan Lyu, Qiyi Zeng

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Article Immunology

UCP2 ameliorates mitochondrial dysfunction, inflammation, and oxidative stress in lipopolysaccharide-induced acute kidney injury

Yue Ding, Yijun Zheng, Jinda Huang, Wanwan Peng, Xinxin Chen, Xiangjin Kang, Qiyi Zeng

INTERNATIONAL IMMUNOPHARMACOLOGY (2019)

Review Biochemistry & Molecular Biology

Paediatric sepsis-associated encephalopathy (SAE): a comprehensive review

John Sieh Dumbuya, Siqi Li, Lili Liang, Qiyi Zeng

Summary: Sepsis-associated encephalopathy (SAE) is a common organ dysfunction in sepsis patients without central nervous system infection. Its pathophysiology involves oxidative stress, cytokine and proinflammatory factors, cerebral circulation disturbances, blood-brain barrier permeability changes, neurotransmitter and amino acid level alterations, and dysfunction of cerebral microvascular cells, mitochondria, microglia, and astrocytes. Diagnosis of SAE is challenging due to the need to exclude CNS infection, and diagnostic tools such as EEG, neuroimaging, and biomarkers are commonly used. Treatment focuses on managing underlying conditions, using antibiotics, supportive therapy, and judicious use of sedative medication like dexmedetomidine. Other potential neuroprotective agents like dexamethasone, melatonin, and magnesium are being explored. Managing modifiable factors is crucial for improving neurological outcomes. However, there are limited experimentation models and treatment strategies for pediatric SAE, and extrapolation from adult models is challenging.

MOLECULAR MEDICINE (2023)

No Data Available